Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection
M Rizzi, V Avellis, A Messina, C Germano… - International Journal of …, 2024 - mdpi.com
To date, the SARS-CoV-2 pandemic still represents a great clinical challenge worldwide,
and effective anti-COVID-19 drugs are limited. For this reason, nutritional supplements have …
and effective anti-COVID-19 drugs are limited. For this reason, nutritional supplements have …
Treatment intensification in kawasaki disease-current perspectives
P Barman, RK Pilania, G Cv, A Thangraj… - Expert Review of …, 2024 - Taylor & Francis
Introduction Intravenous immunoglobulin is the standard of care in Kawasaki disease.
However, a subset of patients exhibits resistance to intravenous immunoglobulin treatment …
However, a subset of patients exhibits resistance to intravenous immunoglobulin treatment …
Tocilizumab as a potential adjunctive therapy to corticosteroids in cryptococcal post-infectious inflammatory response syndrome (PIIRS): a report of two cases
JC Hargarten, SH Anjum, K Ssebambulidde… - Journal of Clinical …, 2023 - Springer
Purpose Non-HIV cryptococcal meningoencephalitis (CM) in previously healthy individuals
is often complicated by a post-infectious inflammatory response syndrome (c-PIIRS) …
is often complicated by a post-infectious inflammatory response syndrome (c-PIIRS) …
Elevated serum levels of T-cell immunoglobulin and mucin-domain containing molecule 3 in patients with systemic inflammation following COVID-19 vaccination
MC Hsieh, WC Yu, CC Weng, WJ Chen… - Journal of the …, 2023 - journals.lww.com
Background: ChAdOx1 nCoV-19 vaccine has been widely used. Some unexpected adverse
effects such as the development of systemic hyper inflammation with multiorgan involvement …
effects such as the development of systemic hyper inflammation with multiorgan involvement …
Treatment of multisystem inflammatory syndrome in children
T Tong, YH Jin, M Wang, FQ Gong - World Journal of Pediatrics, 2024 - Springer
Background Multisystem inflammatory syndrome in children (MIS-C), a relatively uncommon
but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19) …
but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19) …
Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020–2022 Survey of the Pediatric Rheumatology Association of Japan
H Wakiguchi, U Kaneko, S Sato, T Imagawa… - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) in children can be compounded by concurrent
diseases and immunosuppressants. For the first time, we aimed to report the clinical features …
diseases and immunosuppressants. For the first time, we aimed to report the clinical features …
[引用][C] First use of Tocilizumab in the severe form of COVID-19 during the first wave: Clinical case and review of the literature
AM Ounteini, E Devin, A Mehdaoui, H Mahmoud - 2023
[引用][C] JOURNAL OF FUNCTIONAL VENTILATION AND PULMONOLOGY Journal de la Fonction Ventilatoire et de Pneumologie VOLUME 14-ISSUE 44
AM Ounteini, E Devin, A Mehdaoui, H Mahmoud